Lpl Financial LLC Incyte Corp Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Incyte Corp stock. As of the latest transaction made, Lpl Financial LLC holds 22,627 shares of INCY stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,627
Previous 26,702 15.26%
Holding current value
$1.62 Million
Previous $1.62 Million 7.6%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$57.33 - $68.61 $233,619 - $279,585
-4,075 Reduced 15.26%
22,627 $1.5 Million
Q2 2024

Aug 07, 2024
SELL
$51.18 - $63.75 $116,997 - $145,732
-2,286 Reduced 7.89%
26,702 $1.62 Million
Q1 2024

May 10, 2024
BUY
$56.55 - $66.59 $24,655 - $29,033
436 Added 1.53%
28,988 $1.65 Million
Q4 2023

Feb 14, 2024
SELL
$52.16 - $64.19 $859,127 - $1.06 Million
-16,471 Reduced 36.58%
28,552 $1.79 Million
Q3 2023

Nov 13, 2023
BUY
$57.77 - $65.93 $366,666 - $418,457
6,347 Added 16.41%
45,023 $2.6 Million
Q2 2023

Jul 31, 2023
SELL
$60.95 - $75.51 $12,129 - $15,026
-199 Reduced 0.51%
38,676 $2.41 Million
Q1 2023

May 10, 2023
SELL
$70.23 - $86.01 $914,183 - $1.12 Million
-13,017 Reduced 25.08%
38,875 $2.81 Million
Q4 2022

Feb 07, 2023
BUY
$67.18 - $84.11 $389,912 - $488,174
5,804 Added 12.59%
51,892 $4.17 Million
Q3 2022

Nov 14, 2022
BUY
$66.18 - $82.86 $220,247 - $275,758
3,328 Added 7.78%
46,088 $3.07 Million
Q2 2022

Aug 12, 2022
BUY
$66.18 - $83.18 $670,006 - $842,114
10,124 Added 31.02%
42,760 $3.25 Million
Q1 2022

May 16, 2022
BUY
$66.02 - $79.71 $1.78 Million - $2.15 Million
27,026 Added 481.75%
32,636 $2.59 Million
Q4 2021

Feb 14, 2022
SELL
$63.34 - $74.11 $20,648 - $24,159
-326 Reduced 5.49%
5,610 $412,000
Q3 2021

Nov 15, 2021
SELL
$68.67 - $84.02 $19,090 - $23,357
-278 Reduced 4.47%
5,936 $408,000
Q2 2021

Aug 13, 2021
SELL
$79.87 - $87.53 $540,480 - $592,315
-6,767 Reduced 52.13%
6,214 $523,000
Q1 2021

May 14, 2021
BUY
$76.02 - $100.5 $173,249 - $229,039
2,279 Added 21.3%
12,981 $1.06 Million
Q4 2020

Feb 12, 2021
BUY
$80.74 - $97.7 $123,128 - $148,992
1,525 Added 16.62%
10,702 $931,000
Q3 2020

Nov 09, 2020
SELL
$85.07 - $109.69 $255,380 - $329,289
-3,002 Reduced 24.65%
9,177 $824,000
Q2 2020

Aug 13, 2020
SELL
$74.18 - $108.93 $38,499 - $56,534
-519 Reduced 4.09%
12,179 $1.27 Million
Q1 2020

May 14, 2020
SELL
$63.18 - $85.97 $81,754 - $111,245
-1,294 Reduced 9.25%
12,698 $930,000
Q4 2019

Feb 14, 2020
SELL
$73.04 - $95.72 $76,838 - $100,697
-1,052 Reduced 6.99%
13,992 $1.22 Million
Q3 2019

Nov 13, 2019
SELL
$72.82 - $86.52 $422,720 - $502,248
-5,805 Reduced 27.84%
15,044 $1.12 Million
Q2 2019

Aug 09, 2019
SELL
$73.52 - $88.7 $839,966 - $1.01 Million
-11,425 Reduced 35.4%
20,849 $1.77 Million
Q1 2019

May 08, 2019
BUY
$63.56 - $88.17 $634,964 - $880,818
9,990 Added 44.83%
32,274 $2.78 Million
Q4 2018

Feb 07, 2019
SELL
$58.5 - $69.94 $28,840 - $34,480
-493 Reduced 2.16%
22,284 $1.42 Million
Q3 2018

Nov 14, 2018
SELL
$61.75 - $74.23 $679 - $816
-11 Reduced 0.05%
22,777 $1.57 Million
Q2 2018

Aug 14, 2018
BUY
$60.85 - $83.98 $608,439 - $839,716
9,999 Added 78.18%
22,788 $1.53 Million
Q1 2018

May 15, 2018
BUY
$83.06 - $100.98 $42,942 - $52,206
517 Added 4.21%
12,789 $1.07 Million
Q4 2017

Feb 14, 2018
BUY
$93.56 - $116.6 $510,369 - $636,053
5,455 Added 80.02%
12,272 $1.16 Million
Q3 2017

Nov 14, 2017
BUY
$109.15 - $138.27 $253,773 - $321,477
2,325 Added 51.76%
6,817 $791,000
Q2 2017

Aug 14, 2017
BUY
N/A
4,492
4,492 $565,000

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email